Findings from both databases revealed that the intensified mRNA expression of METTL5 was observed in HCC specimens in comparison with adjacent healthy tissues via UALCAN (Fig. 4A) which is consistent with the outcomes of HPA database(Fig. 4B). The gene discussed is METTL5; the disease is hepatocellular carcinoma.